{"id":244355,"date":"2026-09-11T14:33:33","date_gmt":"2026-09-11T09:03:33","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=244355"},"modified":"2026-09-11T14:33:33","modified_gmt":"2026-09-11T09:03:33","slug":"is-gujarat-themis-biosyn-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-gujarat-themis-biosyn-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Gujarat Themis Biosyn a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"

Gujarat Themis Biosyn share price around Rs 418. 12.7% below 52-week high of Rs 479. Q1 FY27 revenue Rs 44 crore, up 21.5% YoY. PAT Rs 11 crore, up 22.2%. PE 115x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Gujarat Themis Biosyn’s Q1 FY27 results were strong, with revenue at Rs 44 crore and PAT climbing 22% to Rs 11 crore. The stock trades at a PE of 115x against an industry average near 51x, so some of this good news is already priced in. The Gujarat Themis Biosyn share price near Rs 418 reflects that optimism, so investors weighing whether Gujarat Themis Biosyn is a good buy today should focus on whether this pace of growth can be sustained rather than just this quarter’s print.<\/p>\n<\/p><\/div>\n

The Gujarat Themis Biosyn share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Gujarat Themis Biosyn is a manufacturer of active pharmaceutical ingredients (APIs), and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 44 crore, up 21.5% year on year, while profit after tax came in at Rs 11 crore, up 22.2% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Gujarat Themis Biosyn share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Gujarat Themis Biosyn share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n